pharma · Solid Tumors · Primary Dysmenorrhea
Topiloric/Uriadec
Topiloric/Uriadec patent portfolio — 52 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- SOUTH SAN FRANCISCO, CA, JP
- Employees
- 2
- Programs
- 12
- Drugs
- 7
- Patents
- 52
Topiloric/Uriadec patents
52 pharmaceutical patents indexed for Topiloric/Uriadec. 1 expire within 24 months.
Topiloric/Uriadec has 52 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 6306444
Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same
expired -
US 6238671
Process for the gentle recovery of extract fractions from hypericum, pharmaceutical preparations containing the same and their use
expired -
US 6117430
Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same
expired -
US 6068816
Process for the mild reduction of germs in pharmaceutical preparations
expired
Frequently asked questions
How many patents does Topiloric/Uriadec have?
52 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Topiloric/Uriadec patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.